Non-Sterile Outsourcing Market
完整報告名稱與涵蓋範圍
Non-Sterile Outsourcing Market, Share & Trends Analysis Report, By Dosage form (Oral, Ear & Eye, Nasal, Topical, Parenteral), By Application (Human Medication, Nutraceuticals, Cosmetics, Medical Devices, Veterinary Health), By Region, and Segment Forecasts, 2024-2031
報告摘要
Valued at USD 7.50 Bn as of 2023, the global Non-Sterile Outsourcing Market is forecasted to climb to USD 10.81 Bn by 2031, reflecting a compound annual growth rate of 4.8% over the 2024–2031 period.
Non-Sterile Outsourcing covers reshaping how healthcare entities approach this space.
Market momentum is bolstered by mounting appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Non-Sterile Outsourcing Market Snapshot
Chapter 4. Global Non-Sterile Outsourcing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Dosage Form Estimates & Trend Analysis
5.1. by Dosage Form & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Dosage Form:
5.2.1. Oral
5.2.1.1. Mixtures
5.2.1.2. Linctures
5.2.1.3. Syrups
5.2.1.4. Elixirs
5.2.1.5. Mouth Washes/Gargles
5.2.1.6. Drops
5.2.2. Ear & Eye
5.2.2.1. Drops
5.2.2.2. Lotions
5.2.3. Nasal
5.2.3.1. Drops
5.2.3.2. Sprays
5.2.4. Topical
5.2.4.1. Gel
5.2.4.2. Cream
5.2.5. Parenteral
Chapter 6. Market Segmentation 2: by End User Estimates & Trend Analysis
6.1. by End User & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
6.2.1. Pharmaceutical Companies
6.2.1.1. Human
6.2.1.2. Veterinary
6.2.2. Cosmeceuticals Companies
6.2.3. Nutraceutical Companies
6.2.4. Medical Device Manufacturers
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Human Medication
7.2.2. Nutraceuticals
7.2.3. Cosmetics
7.2.4. Medical Devices
7.2.5. Veterinary Health
Chapter 8. Non-Sterile Outsourcing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031
8.1.2. North America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.1.3. North America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.4. North America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031
8.2.2. Europe Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.2.3. Europe Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. Europe Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031
8.3.2. Asia Pacific Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.3.3. Asia-Pacific Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Asia Pacific Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031
8.4.2. Latin America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.4.3. Latin America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Latin America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031
8.5.2. Middle East & Africa Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.5.3. Middle East & Africa Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Middle East & Africa Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AbbVie Pharmaceutical Contract Manufacturing
9.2.2. Aenova Group
9.2.3. APPCO Pharmaceutical Corporation
9.2.4. Atral Pharmaceutical
9.2.5. Aurigene Pharmaceutical Services (Dr. Reddy's)
9.2.6. Biological E. Ltd.
9.2.7. BioPlus Life Sciences
9.2.8. Bora Pharmaceuticals
9.2.9. Cambrex Corporation
9.2.10. COC Farmaceutici
9.2.11. Contract Pharmaceuticals Limited (CPL)
9.2.12. DPT Laboratories, Ltd.
9.2.13. Eurofins
9.2.14. JGL d.d.
9.2.15. Mikart
9.2.16. PharmaVision (Vizyon Holding)
9.2.17. Pierre Fabre
9.2.18. TriRx Pharmaceutical Services
9.2.19. UI Pharmaceuticals
9.2.20. Wasdell Group
9.2.21. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們